Ning Wen; Fang Fang; Wenbo Xu; Huaqing Wang; Yong Zhang; Qiru Su; Yao Liu; Haibo Wang; Shuangli Zhu; Xiaoxiao Zhang; Wenzhou Yu; Dongmei Yan; Zhenguo Zhang; Qiu Tan; Fubao Ma; Aihu Dong; Yu Liu; Keli Li; Li Zheng; Lixin Hao; Dongyan Wang; Chunxiang Fan; Wendi Wu; Huiming Luo; Aiqiang Xu; Weizhong Yang; Ning Wen; Fang Fang; Wenbo Xu; Huaqing Wang; Yong Zhang; Qiru Su; Yao Liu; Haibo Wang; Shuangli Zhu; Xiaoxiao Zhang; Wenzhou Yu; Dongmei Yan; Zhenguo Zhang; Qiu Tan; Fubao Ma; Aihu Dong; Yu Liu; Keli Li; Li Zheng; Lixin Hao; Dongyan Wang; Chunxiang Fan; Wendi Wu; Huiming Luo; Aiqiang Xu; Weizhong Yang

doi:10.46234/ccdcw2020.260

[1]

Sutter RW, Kew OM, Cochi SL, Aylward RB. Poliovirus vaccine—live. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia, PA: Saunders Elsevier. 2008;p. 638.

[2]

Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013−2018. http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EndGameStratPlan_20130208_ENG.pdf. [2013-4-10].

[3]

Polio vaccines: WHO position paper, January 2014. Wkly Epidemiol Rec 2014;89(9):73 − 92. https://pubmed.ncbi.nlm.nih.gov/24707513/.

[4]

Progress towards global poliomyelitis eradication: preparation for the oral poliovirus vaccine cessation era. Wkly Epidemiol Rec 2004;79(39):349 − 55. https://pubmed.ncbi.nlm.nih.gov/15571172/.

[5]

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec 2010;85(23):213 − 28. https://pubmed.ncbi.nlm.nih.gov/20545051/.

[6]

World Health Organization. Report of the interim meeting of the Technical Consultative Group (TCG) on the global eradication of poliomyelitis. Geneva: World Health Organization, 2003. http://apps.who.int/iris/bitstream/10665/67859/1/WHO_VB_03.04_eng.pdf.

[7]

Joce R, Wood D, Brown D, Begg N. Paralytic poliomyelitis in England and Wales, 1985−91. BMJ 1992;305(6845):79 − 82. http://dx.doi.org/10.1136/bmj.305.6845.79.

[8]

Andrus JK, Strebel PM, de Quadros CA, Olivé JM. Risk of vaccine-associated paralytic poliomyelitis in latin America, 1989−91. Bull World Health Organ 1995;73(1):33 − 40. https://pubmed.ncbi.nlm.nih.gov/7704923/.

[9]

Teixeira-Rocha ES, Carmo EH, Tavares-Neto J. The occurrence of vaccine-associated paralytic poliomyelitis in Brazil, 1995 to 2001. Rev Panam Salud Publica 2005;18(1):21 − 4. https://scielosp.org/article/rpsp/2005.v18n1/21-24/pt/.

[10]

Hao LX, Toyokawa S, Kobayashi Y. Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000. Jpn J Infect Dis 2008;61(2):100 − 3. https://pubmed.ncbi.nlm.nih.gov/18362395/.

[11]

Kohler KA, Banerjee K, Gary Hlady W, Andrus JK, Sutter RW. Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine. Bull World Health Organ 2002;80(3):210 − 6. https://pubmed.ncbi.nlm.nih.gov/11984607/.

[12]

Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA 2004;292(14):1696 − 701. http://dx.doi.org/10.1001/jama.292.14.1696.

[13]

Landaverde JM, Trumbo SP, Danovaro-Holliday MC, Cochi SE, Gandhi R, Ruiz-Matus C. Vaccine-associated paralytic poliomyelitis in the postelimination era in Latin America and the Caribbean, 1992-2011. J Infect Dis 2014;209(9):1393 − 402. http://dx.doi.org/10.1093/infdis/jit602.

[14]

Platt LR, Estívariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. J Infect Dis 2014;210(Suppl 1):S380 − 9. http://dx.doi.org/10.1093/infdis/jiu184.